Ophthalmology Times' David Hutton speaks with John A.
Jeanne Hecht, Ora chief executive officer, discusses the significance of clinical research as a care option with Sheryl Stevenson, Ophthalmology Times
Ophthalmology Times' Sheryl Stevenson speaks with Kala Pharmaceuticals' James Yanek, director of professional relations, and Desiree Owen, OD, associate director of Medical Science Liaisons at
Ophthalmology Times' David Hutton speaks with Cynthia Matossian, MD, FACS, on her presentation "Real-world efficacy of DEXYCU (dexamethasone intraocular suspension) 9% retrospectiv
Ophthalmology Times' Sheryl Stevenson speaks with Shervin Korangy, president and CEO of BVI Medical, on the latest updates and products in the pipeline for the company, how they're assisting with and providing resources for healt
Ophthalmology Times' Sheryl Stevenson speaks with Roger Kennedy, director of marketing at Bio-Tissue, on the company's research posters presented at the 2020 ASCRS virtual meeting, as well as updates on operations amid the corona
Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative
Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virt
Ophthalmology Times' Sheryl Stevenson speaks with Mark Hagler, senior vice president, head of Ophthalmics, Oncology & LTC at Sun Pharmaceuticals, on the company's ongoing research and portfolio, as well as how its operations
Ophthalmology Times' Sheryl Stevenson sits down with Kristen Brotherson, vice president of U.S.